09:53 AM EST - BioVaxys Technology Corp : Announces that it has agreed to settle an aggregate of $300,000 in debt with one vendor through the issuance of common shares to be issued at a deemed price of $0.15 per common share. All securities issued in connection with the Debt Settlement are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation. Closing of the Debt Settlement is subject to a number of conditions, including receipt of all necessary regulatory approvals. BioVaxys Technology Corp
shares C.BIOV are trading -$0.02 at $0.16.
